VAS972: Feasibility study

In a placebo-controlled 20-patient feasibility study in Canada, VAS said 2 standard

Read the full 128 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE